Seek Returns

Danaher (DHR) Stock Analysis

This is a peer-relative look at Danaher (DHR): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Company profile fields for Danaher (DHR)
Profile ItemDHR
NameDanaher Corp.
Country/RegionUnited States
GICS SectorHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & Services
Market Capitalization161.86 billion USD
CurrencyUSD
ExchangeNYSE
Listing DateDecember 29, 1978
Security TypeCommon Stock

Price Performance

Cumulative Growth

DHR
GSPC
Loading price history…
Danaher (DHR) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Danaher (DHR) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Danaher (DHR) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Danaher (DHR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: DHRIndustry group median
Total Return (1Y)11.88%24.62%
Total Return (3Y, Annualized)6.67%20.37%
Total Return (5Y, Annualized)-2.05%-4.02%

Risk Profile

Drawdown History

DHR
GSPC
Loading price history…
Danaher (DHR) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Danaher (DHR) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Danaher (DHR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: DHRIndustry group median
Volatility (1Y, Annualized)30.61%66.36%
Beta (5Y)0.760.93
Max Drawdown (5Y)-43.31%-80.19%

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. DHR is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

Danaher (DHR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: DHRIndustry group median
Sharpe Ratio (1Y)0.250.36
Sortino Ratio (1Y)0.350.58

Profitability

ROE (TTM)

Danaher (DHR) posts ROE of 8.19%, in the upper peer quartile. That suggests the company earns more from each dollar of shareholders’ equity than most industry peers, a useful capital-efficiency signal.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.19%

Group distribution
Max
109.18%
DHR
8.19%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Largest peers
LLY
86.02%
NVS
24.33%
AZN
22.57%
JNJ
20.02%
DHR
8.19%
MRK
5.06%
ABBV
--
Loading chart…
Where Danaher (DHR) stands on ROE within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Net Margin (TTM)

Danaher (DHR) keeps 16.91% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

16.91%

Group distribution
Max
18.05%
DHR
16.91%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Largest peers
LLY
31.90%
AZN
17.68%
NVS
17.49%
DHR
16.91%
JNJ
16.20%
ABBV
15.67%
MRK
3.64%
Loading chart…
Where Danaher (DHR) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

Danaher (DHR) turns 21.13% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.13%

Group distribution
Max
83.12%
DHR
21.13%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Largest peers
LLY
53.66%
ABBV
39.59%
MRK
35.22%
NVS
34.27%
AZN
29.57%
JNJ
25.74%
DHR
21.13%
Loading chart…
Where Danaher (DHR) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

Danaher (DHR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: DHRIndustry group median
ROE (TTM)8.19%-26.66%
ROA (TTM)4.06%-12.50%
Net Margin (TTM)16.91%0.00%
Operating Margin (TTM)21.13%0.00%
Gross Margin (TTM)59.36%37.87%

Growth

Revenue Growth

Danaher (DHR) grew revenue 2.90%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.

Loading chart…
Danaher (DHR): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

Danaher (DHR) grew earnings per share -4.54%, roughly around the peer group's normal range. Bottom-line momentum looks broadly typical for the industry.

Loading chart…
Danaher (DHR): EPS Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

Growth Metrics

Danaher (DHR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: DHRIndustry group median
Revenue Growth (YoY)2.90%11.45%
Revenue Growth (3Y CAGR)-2.67%9.94%
EPS Growth (YoY)-4.54%4.28%
EPS Growth (3Y CAGR)-19.44%4.17%

Financial Strength

Current Ratio (MRQ)

Danaher (DHR) has current ratio of 1.63, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.63

Group distribution
Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
DHR
1.63
Min
0.10
Largest peers
DHR
1.63
LLY
1.39
MRK
1.35
JNJ
1.02
AZN
1.01
NVS
0.88
ABBV
0.87
Loading chart…
Where Danaher (DHR) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

Danaher (DHR) has debt-to-equity ratio of 0.52, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.52

Group distribution
Max
1.42
Q3
0.65
DHR
0.52
Median
0.15
Q1
0.02
Min
0.00
Largest peers
NVS
1.29
LLY
1.23
MRK
1.20
AZN
0.66
JNJ
0.55
DHR
0.52
ABBV
--
Loading chart…
Where Danaher (DHR) stands on debt-to-equity ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Financial Strength Metrics

Danaher (DHR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: DHRIndustry group median
Current Ratio (MRQ)1.635.52
Debt / Equity (MRQ)0.520.15
Net Debt / EBITDA2.681.08

Dividends

Dividend Yield (TTM)

Danaher (DHR) has dividend yield of 0.67%, above the entire industry range. That headline income is large, but yields this far above peers often come from a falling share price or an at-risk payout, so dividend safety matters more than the percentage itself.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.67%

Group distribution
DHR
0.67%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
NVS
2.88%
ABBV
2.40%
MRK
2.29%
JNJ
1.94%
AZN
1.73%
DHR
0.67%
LLY
0.49%
Loading chart…
Where Danaher (DHR) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

Danaher (DHR) has payout ratio of 25.17%, above the peer distribution for its industry. The dividend consumes more reported earnings than peers normally do, leaving unusually thin earnings cover.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.17%

Group distribution
DHR
25.17%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
MRK
343.43%
ABBV
117.35%
NVS
90.46%
JNJ
80.12%
AZN
45.38%
DHR
25.17%
LLY
21.71%
Loading chart…
Where Danaher (DHR) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

Danaher (DHR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: DHRIndustry group median
Dividend Yield (TTM)0.67%0.00%
Dividend Payout Ratio (TTM)25.17%0.00%

Valuation

P/E Ratio (TTM)

Danaher (DHR) trades at P/E ratio of 38.12, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

38.12

Group distribution
Max
85.34
Q3
43.46
DHR
38.12
Median
26.69
Q1
13.30
Min
0.07
Largest peers
MRK
148.21
ABBV
50.05
LLY
43.95
JNJ
41.92
DHR
38.12
NVS
31.02
AZN
26.37
Loading chart…
Where Danaher (DHR) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/S Ratio (TTM)

Danaher (DHR) trades at 6.32 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.32

Group distribution
Max
58.18
Q3
25.77
Median
7.30
DHR
6.32
Q1
3.01
Min
0.01
Largest peers
LLY
13.95
ABBV
7.80
JNJ
6.69
DHR
6.32
MRK
5.37
NVS
5.35
AZN
4.63
Loading chart…
Where Danaher (DHR) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

Danaher (DHR) trades at 3.02 on P/B ratio, roughly in line with the industry’s normal price-to-book range. Its balance sheet is not being priced at a clear discount or premium versus peers.

DHR

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.02

Group distribution
Max
13.53
Q3
6.54
Median
3.25
DHR
3.02
Q1
1.69
Min
-5.59
Largest peers
LLY
29.96
NVS
8.25
JNJ
8.16
MRK
8.06
AZN
5.59
DHR
3.02
ABBV
-112.34
Loading chart…
Where Danaher (DHR) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

Danaher (DHR) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: DHRIndustry group median
P/E Ratio (TTM)38.1226.69
P/S Ratio (TTM)6.327.30
P/B Ratio (MRQ)3.023.25
Free Cash Flow Yield (TTM)2.93%-1.66%